Literature DB >> 21890637

Ubiquitin-specific cysteine protease 2a (USP2a) regulates the stability of Aurora-A.

Yan Shi1, Larry R Solomon, Ana Pereda-Lopez, Vincent L Giranda, Yan Luo, Eric F Johnson, Alexander R Shoemaker, Joel Leverson, Xuesong Liu.   

Abstract

The ubiquitin/proteasome pathway plays critical roles in virtually all aspects of cell biology. Enzymes of the ubiquitin pathway add (ligases) or remove (deubiquitinases) ubiquitin tags to or from their target proteins in a selective fashion. USP2a is a member of a subfamily of deubiquitinases, called ubiquitin-specific cysteine proteases (USPs). Although USP2a has been reported to be a bona fide oncogene that regulates the stability of MDM2, MDMX, and FAS, it is likely that there are other unidentified substrates for USP2a. In this study, we show that USP2a mediates mitotic progression by regulating the stability of Aurora-A. Through cell-based screening of a USP siRNA library, we discovered that knockdown of USP2a reduced the protein levels of Aurora-A. USP2a interacts with Aurora-A directly in vitro and in vivo. In addition, Aurora-A is a substrate for USP2a in vitro and in vivo. Our study provides a novel mechanism for the role of USP2a in mediating the stability of Aurora-A.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21890637      PMCID: PMC3234721          DOI: 10.1074/jbc.M111.231498

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  p53 and human cancer: the first ten thousand mutations.

Authors:  P Hainaut; M Hollstein
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

2.  Divergent N-terminal sequences target an inducible testis deubiquitinating enzyme to distinct subcellular structures.

Authors:  H Lin; A Keriel; C R Morales; N Bedard; Q Zhao; P Hingamp; S Lefrançois; L Combaret; S S Wing
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells.

Authors:  Patrick Meraldi; Reiko Honda; Erich A Nigg
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

4.  Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells.

Authors:  Toru Hirota; Naoko Kunitoku; Takashi Sasayama; Tomotoshi Marumoto; Dongwei Zhang; Masayuki Nitta; Katsuyoshi Hatakeyama; Hideyuki Saya
Journal:  Cell       Date:  2003-09-05       Impact factor: 41.582

Review 5.  Drug discovery in the ubiquitin regulatory pathway.

Authors:  Brian R Wong; Francesco Parlati; Kunbin Qu; Susan Demo; Todd Pray; Jianing Huang; Donald G Payan; Mark K Bennett
Journal:  Drug Discov Today       Date:  2003-08-15       Impact factor: 7.851

6.  MdmX is a substrate for the deubiquitinating enzyme USP2a.

Authors:  N Allende-Vega; A Sparks; D P Lane; M K Saville
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

7.  Probing the dynamics and functions of aurora B kinase in living cells during mitosis and cytokinesis.

Authors:  Maki Murata-Hori; Masaaki Tatsuka; Yu-Li Wang
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

8.  Degradation of human Aurora-A protein kinase is mediated by hCdh1.

Authors:  Sei ichi Taguchi; Kei Honda; Kazumitsu Sugiura; Akio Yamaguchi; Koichi Furukawa; Takeshi Urano
Journal:  FEBS Lett       Date:  2002-05-22       Impact factor: 4.124

9.  Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit.

Authors:  Laurie E Littlepage; Joan V Ruderman
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

10.  AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol.

Authors:  Shubha Anand; Sue Penrhyn-Lowe; Ashok R Venkitaraman
Journal:  Cancer Cell       Date:  2003-01       Impact factor: 31.743

View more
  30 in total

1.  USP2a protein deubiquitinates and stabilizes the circadian protein CRY1 in response to inflammatory signals.

Authors:  Xin Tong; Katie Buelow; Anirvan Guha; Rebecca Rausch; Lei Yin
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 2.  Deubiquitinases: Pro-oncogenic Activity and Therapeutic Targeting in Blood Malignancies.

Authors:  Blanca T Gutierrez-Diaz; Wei Gu; Panagiotis Ntziachristos
Journal:  Trends Immunol       Date:  2020-03-02       Impact factor: 16.687

3.  The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer.

Authors:  Jayoung Kim; Wun-Jae Kim; Zhiqian Liu; Massimo Loda; Michael R Freeman
Journal:  Cell Cycle       Date:  2012-03-15       Impact factor: 4.534

Review 4.  Issues in interpreting the in vivo activity of Aurora-A.

Authors:  Elena Shagisultanova; Roland L Dunbrack; Erica A Golemis
Journal:  Expert Opin Ther Targets       Date:  2014-11-11       Impact factor: 6.902

5.  The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation.

Authors:  Z Liu; S M Zanata; J Kim; M A Peterson; D Di Vizio; L R Chirieac; S Pyne; M Agostini; M R Freeman; M Loda
Journal:  Oncogene       Date:  2012-06-18       Impact factor: 9.867

6.  Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin.

Authors:  Jongchan Kim; Fatemeh Alavi Naini; Yutong Sun; Li Ma
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

7.  NEDD9 depletion destabilizes Aurora A kinase and heightens the efficacy of Aurora A inhibitors: implications for treatment of metastatic solid tumors.

Authors:  Ryan J Ice; Sarah L McLaughlin; Ryan H Livengood; Mark V Culp; Erik R Eddy; Alexey V Ivanov; Elena N Pugacheva
Journal:  Cancer Res       Date:  2013-03-28       Impact factor: 12.701

8.  Transient kinetic analysis of USP2-catalyzed deubiquitination reveals a conformational rearrangement in the K48-linked diubiquitin substrate.

Authors:  William P Bozza; Qin Liang; Ping Gong; Zhihao Zhuang
Journal:  Biochemistry       Date:  2012-12-04       Impact factor: 3.162

Review 9.  Aurora A kinase (AURKA) in normal and pathological cell division.

Authors:  Anna S Nikonova; Igor Astsaturov; Ilya G Serebriiskii; Roland L Dunbrack; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2012-08-03       Impact factor: 9.261

Review 10.  TGF-β signaling pathway mediated by deubiquitinating enzymes.

Authors:  Soo-Yeon Kim; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2018-10-22       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.